Participants Print

Participants are co-applicants of the project and full members. They have an official vote on formal issues in the Governance Council that is responsible for the definition of the appropriate strategy and processes, and is required for the approval of reports and any changes of the work plan.

Participant no. Participant organisation name Country
1 Medical University of Graz (K. Zatloukal) Austria
2 National Public Health Institute (L. Peltonen, J. Muilu) Finland
3 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH (E. Wichmann, T. Meitinger) Germany
4 Uppsala Universitet (U. Landegren, M. Taussig, T. Risch) Sweden
5 Karolinska Institutet (J.-E. Litton) Sweden
6 INSERM (G. Dagher, C. Libersa, A. Cambon-Thomsen) France
7 University of Manchester (M. Yuille, B. Ollier) United Kingdom
8 International Agency for Research on Cancer
(M. Pasterk, P. Hainaut)
France
9 Academisch Ziekenhuis Leiden (G.J.B. van Ommen) The Netherlands
10 Univ. of Malta (A. Felice) Malta
11 Norwegian University of Science and Technology
(K. Hveem)
Norway
12 Semmelweis University (A. Falus) Hungary
13 EGP of the University of Tartu (A. Metspalu) Estonia
14 National DNA Bank, University of Salamanca (A. Orfao) Spain
15 Fondazione Telethon (L. Monaco) Italy
16 Féderation Hospitalière de France - FHF (E. Devilliers) France
17 Irish Clinical Research Infrastructure Network (P. Doran) Ireland
18 Helmholtz Gemeinschaft (S. Joos) Germany
19 Institut National du Cancer (P. Boucher) France
20 Comitato Nazionale per la Biosicurezza, le Biotecnologie e le Scienze della Vita, Istituto Superiore di Sanita
(G. D'Agnolo)
Italy
21 Max-Planck-Institut für Molekulare Genetik (H. Lehrach) Germany
22 Instituto de Salud Carlos III (R. de Andrés-Medina) Spain
23 VITRO Ltd (A. Fernandez) Spain
25 Ensembl Functional Genomics, European Genotype Archive (P. Flicek) United Kingdom
27 Norwegian Institute of Public Health (K. Hveem) Norway
28 Erasmus MC Rotterdam (P. Riegman) The Netherlands
29 Istituto Nazionale per la Ricerca sul Cancro, Biological Bank and Cell Factory (B. Parodi, P. Romano) Italy
30 Institute for Biomedical Technologies (L. Milanesi) lItaly
31 Research Infrastructure and Special Initiatives Unit Health Research Board (A. Cody) Ireland
32 Medical Research Council (M. Palmer) United Kingdom
33 UK Biobank Ltd (T. Peakman) United Kingdom
34 Ministry of Education, Culture and Science (J.W.A. Ridder) The Netherlands
35 The Icelandic Centre for Research (K. Valgeirsdóttir) Iceland
36 University Hospital Groningen
(B.H.R. Wolffenbuttel, J.L. Hillege)
The Netherlands
37 Dutch Federation of University Medical Centers (D.A. Legemate) The Netherlands
38 The Netherlands Organisation for Health Research and Development (E. Beem) The Netherlands
39 Fraunhofer IBMT (H. Zimmermann) Germany
40 Bundesministerium für Bildung und Forschung (F. Laplace) Germany
41 Bundesministerium für Wissenschaft und Forschung (R. Klang) Austria
43 deCODE genetics (U. Thorsteinsdottir) Iceland
44 Life Science Governance Institute (H. Gottweis) Austria
46 Cardiff University (R. Chadwick) United Kingdom
47 Alleanza contro il cancro (P.L. Spagnoli) Italy
49 Fundación para el desarrollo de la investigación en Genómica y Proteómica (J.L. Jorcano) Spain
50 Ministry of Education and Research, Estonia
(I. Reimand)
Estonia
51 Babraham Bioscience Technologies (M. Taussig) United Kingdom
52 Hellenic Republic Ministry of Development, General Secretariat For Research & Technology (I.A. Tsoukalas) Greece
53 Biomedical Research Foundation of the Academy of Athens (D. Thanos) Greece
54 Universität Klagenfurt (J. Eder) Austria
55 University of Turku (E. Vuorio) Finland
56 Legal Pathways b.v. (J. Bovenberg) The Netherlands
57 Irish Platform for Patients' Organisations, Science & Industry  (E. Mulroe) Ireland
58 Institut Mérieux (C. Bréchot) France
(59) [International Prevention Research Institute (P. Boyle, M. Pasterk)] (France)

53 Participants as of March 2nd 2010  (IPRI is currently included as new participant to the Grant Agreement due to a change of affiliation).